Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 11 | 2022 | 2001 | 0.890 |
Why?
|
| Fibrinogen | 3 | 2019 | 212 | 0.760 |
Why?
|
| Glioblastoma | 7 | 2022 | 1844 | 0.600 |
Why?
|
| STAT5 Transcription Factor | 3 | 2014 | 223 | 0.580 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 717 | 0.570 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2020 | 2395 | 0.540 |
Why?
|
| ErbB Receptors | 5 | 2013 | 2329 | 0.450 |
Why?
|
| bcl-X Protein | 1 | 2012 | 199 | 0.410 |
Why?
|
| Brain Neoplasms | 8 | 2022 | 4995 | 0.370 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 2980 | 0.350 |
Why?
|
| Serpins | 2 | 2006 | 76 | 0.310 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2017 | 204 | 0.250 |
Why?
|
| Apoptosis | 6 | 2017 | 7756 | 0.210 |
Why?
|
| Ultrasonic Waves | 1 | 2021 | 8 | 0.200 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 505 | 0.200 |
Why?
|
| Receptors, Chemokine | 1 | 2020 | 117 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 241 | 0.170 |
Why?
|
| Mice | 15 | 2022 | 35298 | 0.170 |
Why?
|
| Disease Progression | 4 | 2019 | 6890 | 0.160 |
Why?
|
| RNA Interference | 4 | 2013 | 1411 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 2012 | 880 | 0.150 |
Why?
|
| Mitochondria | 1 | 2005 | 1306 | 0.150 |
Why?
|
| Animals | 18 | 2022 | 60962 | 0.150 |
Why?
|
| Cell Nucleus | 2 | 2012 | 1644 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 1876 | 0.140 |
Why?
|
| Proteins | 1 | 2005 | 1986 | 0.140 |
Why?
|
| raf Kinases | 1 | 2016 | 81 | 0.130 |
Why?
|
| Aurora Kinase A | 2 | 2014 | 211 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2014 | 80 | 0.120 |
Why?
|
| Fibrin | 1 | 2014 | 90 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 383 | 0.110 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1069 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 7157 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 152 | 0.100 |
Why?
|
| Aurora Kinases | 1 | 2012 | 194 | 0.100 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 14851 | 0.100 |
Why?
|
| Signal Transduction | 7 | 2020 | 12136 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 867 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2006 | 1101 | 0.100 |
Why?
|
| Gonanes | 1 | 2011 | 47 | 0.100 |
Why?
|
| Phosphotyrosine | 1 | 2011 | 121 | 0.090 |
Why?
|
| Mice, Nude | 6 | 2016 | 4343 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2013 | 4885 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 424 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2012 | 480 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2371 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 4230 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3106 | 0.080 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 706 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 833 | 0.080 |
Why?
|
| Protein Transport | 2 | 2012 | 745 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2011 | 1016 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 1469 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 3480 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 12429 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 1574 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 2221 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2013 | 5509 | 0.070 |
Why?
|
| Cell Survival | 1 | 2012 | 3061 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2005 | 118 | 0.060 |
Why?
|
| Cisplatin | 1 | 2012 | 2456 | 0.060 |
Why?
|
| Humans | 17 | 2022 | 270303 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2005 | 78 | 0.060 |
Why?
|
| Inflammation | 1 | 2014 | 2570 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 480 | 0.060 |
Why?
|
| Ion Channels | 1 | 2005 | 226 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 590 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2005 | 435 | 0.060 |
Why?
|
| Biomarkers | 1 | 2014 | 5162 | 0.050 |
Why?
|
| Caspases | 1 | 2005 | 685 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2012 | 243 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2020 | 25 | 0.050 |
Why?
|
| Prognosis | 1 | 2019 | 22228 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 4884 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2016 | 1336 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 147 | 0.040 |
Why?
|
| Breast | 1 | 2006 | 1362 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 30718 | 0.040 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2017 | 18 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7417 | 0.040 |
Why?
|
| Autophagy | 2 | 2016 | 931 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2016 | 7300 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 991 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 6392 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 703 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6269 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 80561 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 292 | 0.030 |
Why?
|
| Mutation | 2 | 2012 | 15578 | 0.030 |
Why?
|
| Costimulatory and Inhibitory T-Cell Receptors | 1 | 2014 | 20 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 10092 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2014 | 190 | 0.030 |
Why?
|
| Nuclear Export Signals | 1 | 2012 | 10 | 0.030 |
Why?
|
| E-Box Elements | 1 | 2012 | 12 | 0.030 |
Why?
|
| Nuclear Localization Signals | 1 | 2012 | 46 | 0.030 |
Why?
|
| Aged | 1 | 2019 | 72685 | 0.030 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 41 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 1656 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2014 | 582 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 9064 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2012 | 236 | 0.020 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2011 | 22 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 89347 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 849 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 512 | 0.020 |
Why?
|
| Phosphopeptides | 1 | 2011 | 67 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 2402 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 1698 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 1706 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1512 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 2208 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 383 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 1952 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 1503 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 1431 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 1533 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1096 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 2316 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 4277 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 1138 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 813 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2006 | 59 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 3480 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 1595 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2006 | 129 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 1289 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 2347 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 2115 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3596 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3665 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 1896 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 1421 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2084 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 2498 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6222 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 2942 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 34144 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 4929 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 1850 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2012 | 5364 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 10623 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 16258 | 0.010 |
Why?
|
| Male | 2 | 2016 | 127343 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 15695 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 16050 | 0.000 |
Why?
|